Genomic Health (GHDX) Misses Q1 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Genomic Health Announces First Quarter 2015 Financial Results and Reports Record Oncotype DX® Test Volume
May 5, 2015 4:01 PM EDTREDWOOD CITY, Calif., May 5, 2015 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today reported financial results and business progress for the quarter ended March 31, 2015.
Product revenue was $68.2 million in the first quarter of 2015, compared with $67.0 million for the first quarter of 2014, an increase of 2 percent. On a constant currency basis, product revenue increased 3 percent compared with the prior year.Â
International product revenue was $10.4 million in the first quarter of 2015 and represented 15 percent of product revenue in the quarter.
Reported total product revenue was impacted negatively by $0.8 million... More



